Health
Using mRNA therapies or CRISPR gene editing to treat cystic fibrosis – News-Medical.Net
The potential for treating cystic fibrosis (CF) using mRNA therapies or CRISPR gene editing is possible regardless of the causative mutation. CF clinical trials…
Reviewed by Emily Henderson, B.Sc.Oct 8 2020
The potential for treating cystic fibrosis (CF) using mRNA therapies or CRISPR gene editing is possible regardless of the causative mutation. CF clinical trials showing that a genotype-agnostic gene therapy for CF is possible are reviewed in the peer-reviewed journal Human Gene Therapy.
Treating CF by delivering mRNA that encodes CFTR has the potential to work in any CF patient, independent of the underlying mutation. Another potential treatment is …
-
General12 hours agoVictorian school teacher charged with soliciting child abuse material
-
Business21 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business23 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
Business20 hours agoHere’s what analysts expect for the BHP share price in the coming year